Emergent BioSolutions

Q3 2025 +36.90%Q2 2025 +36.20%Q1 2025 +35.03%Q4 2024 -6.44%Q3 2024 +22.77%Q2 2024 -41.15%Q1 2024 +75.53%Q4 2023 -18.77%Q3 2023 -8.90%Q2 2023 -20.00%Q1 2023 +18.53%Q4 2022 -9.70%Q3 2022 -36.70%Q2 2022 -12.64%Q1 2022 -11.21%Q4 2021 -6.66%Q3 2021 -37.04%Q2 2021 +1.14%Q1 2021 -1.72%Q4 2020 -15.89%Q3 2020 -6.11%Q2 2020 +18.05%Q1 2020 +6.42%Q4 2019 +2.11%Q3 2019 -5.40%Q2 2019 +1.54%Q1 2019 -8.05%Q4 2018 -2.79%Q3 2018 +5.97%Q2 2018 +3.87%Q1 2018 -4.04%Q4 2017 -3.00%Q3 2017 +7.04%Q2 2017 -1.10%Q1 2017 -3.47%Q4 2016 +0.10%Q3 2016 +9.79%Q2 2016 -2.10%Q1 2016 +0.92%Q4 2015 -3.83%Q3 2015 +2.47%Q2 2015 +5.19%Q1 2015 -1.97%Q4 2014 -3.60%Q3 2014 +7.59%Q2 2014 -2.64%Q1 2014 -10.55%Q4 2013 +9.07%Q3 2013 +9.13%Q2 2013 +1.56%Q1 2013 -5.02%Q4 2012 +1.84%Q3 2012 +8.43%Q2 2012 +1.05%Q1 2012 +4.91%Q1 2011 +4.56%Q4 2011 +4.56%Q4 2009 +8.05%Q3 2010 -5.27%Q3 2011 -5.27%Q2 2010 -8.24%Q2 2011 -8.24%Q4 2010 -8.24%Q1 2010 -1.51%

Aug 01, 2019

•

Jun 30, 2019

Emergent BioSolutions Q2 2019 Earnings Report

Previous year: $1.14B

+103.8%

Emergent BioSolutions

Unlock previous datapoints

Upgrade

Emergent BioSolutions

Unlock previous datapoints

Upgrade

Revenue by Segment

Anthrax MCM Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Other Products Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Contracts and Grants Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Emergent BioSolutions

Products

Get in Touch

Resources

Emergent BioSolutions

Emergent BioSolutions Q2 2019 Earnings Report

Emergent BioSolutions

Emergent BioSolutions

Revenue by Segment

Anthrax MCM Revenue

Other Products Revenue

Contracts and Grants Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Emergent BioSolutions Revenue by Segment